Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Device malfunctions during routine maintenance are reportable -- FDA warning letter to Zoll.

This article was originally published in The Gray Sheet

Executive Summary

DEVICE MALFUNCTIONS DURING ROUTINE MAINTENANCE ARE REPORTABLE, FDA SAYS in a Nov. 21 warning letter to Zoll Medical. The warning letter, which follows an inspection conducted in September and October, cites two specific instances -- one in which a PD 1200 external defibrillator discharged when only one of the discharge buttons was pressed, and another in which a PD 1600 defibrillator shut down after three discharges with good batteries. Both events occurred during routine maintenance of the device and should have been reported because a reoccurrence "would be likely to cause or contribute to a death or serious injury," FDA says.



Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts